Login/Sign Up
Vestrant 250 Injection 1's
Vestrant 250 Injection 1's is used to treat breast cancer in postmenopausal women. It contains Fulvestrant, which works by inhibiting some of the actions of estrogen (female sex hormone which may help cancer cells grow in women with breast cancer) and reducing the amount that is in the body. Thus, it helps in reducing breast cancer tumour growth. In some cases, Vestrant 250 Injection 1's may cause certain common side effects such as injection site reactions like pain and/or inflammation, weakness, nausea, tiredness, headache or joint and musculoskeletal pain.
₹12950*
₹11007.5*
MRP ₹12950
15% CB
₹1942.5 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Whats That
Vestrant 250 Injection 1's belongs to the class of estrogen blockers used to treat breast cancer in postmenopausal women. Breast cancer is a type of cancer that develops when the breast cells begin to grow abnormally.
Vestrant 250 Injection 1's contains Fulvestrant, which works by inhibiting some of the actions of estrogen (female sex hormone which may help cancer cells grow in women with breast cancer) and reducing the amount that is in the body. Thus, it helps in reducing breast cancer tumour growth.
Vestrant 250 Injection 1's will be administered by a healthcare professional; do not self-administer. In some cases, Vestrant 250 Injection 1's may cause certain common side effects such as injection site reactions like pain and/or inflammation, weakness, nausea, tiredness, headache or joint and musculoskeletal pain. Most of these side effects of Vestrant 250 Injection 1's do not require medical attention and gradually resolve over time. However, if these side effects persist or worsen, please consult your doctor.
If you are allergic to Fulvestrant or any other medicines, please tell your doctor. Vestrant 250 Injection 1's is not recommended for pregnant women as it may harm an unborn baby. Vestrant 250 Injection 1's is contraindicated for use during lactation. Avoid alcohol consumption while receiving Vestrant 250 Injection 1's. Avoid driving or operating machinery if you feel tired or weak after receiving Vestrant 250 Injection 1's.
Vestrant 250 Injection 1's contains Fulvestrant, used to treat breast cancer in postmenopausal women. Additionally, Vestrant 250 Injection 1's may be used in combination with palbociclib to treat women with a type of breast cancer called hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that is locally advanced or has spread to other parts of the body (metastatic).
If you are allergic to Fulvestrant or any other medicines, please tell your doctor. Vestrant 250 Injection 1's is not recommended for pregnant women as it may harm an unborn baby. Using effective contraception while being treated with Vestrant 250 Injection 1's and for two years after the last dose is advised. Vestrant 250 Injection 1's is contraindicated for use during lactation. Avoid alcohol consumption while receiving Vestrant 250 Injection 1's. Avoid driving or operating machinery if you feel tired or weak after receiving Vestrant 250 Injection 1's.
Drug-Drug Interaction: If you are taking blood thinners, other anti-cancer medicines, tamoxifen or any medicine containing oestrogen (female sex hormone), inform your doctor.
Drug-Food Interaction: No interactions found.
Drug-Disease Interaction: If you have osteoporosis (loss of bone density), previous problems with blood clots, bleeding disorders or low numbers of platelets (which help blood clotting), and liver or kidney problems, inform your doctor before receiving Vestrant 250 Injection 1's.
Breast cancer: It is a type of cancer that develops in the breast when the cells grow abnormally. The tumor cells invade other healthy breast cells and can travel to lymph nodes, a primary pathway for the cancer cells to move to other parts of the body. Symptoms include a lump in the breast or tissue thickening which feels different than the normal surrounding tissues, breast pain, redness, swelling, nipple discharge other than breast milk, bloody discharge, unexplained change in shape, size, or appearance of the breast, peeling, flaking or scaling of the skin, and a lump or swelling under the arm.
Alcohol
Caution
Avoid alcohol consumption while receiving this medicine. If you have any concerns, please discuss them with your doctor.
Pregnancy
Unsafe
Vestrant 250 Injection 1's is not recommended for use during pregnancy as it may harm the unborn baby. You are advised to use effective contraception while being treated with Vestrant 250 Injection 1's and for two years after your last dose.
Breast Feeding
Unsafe
Vestrant 250 Injection 1's is contraindicated for use during lactation, or you are recommended to avoid breastfeeding while on treatment with Vestrant 250 Injection 1's.
Driving
Safe if prescribed
Vestrant 250 Injection 1's usually does not affect your ability to drive or operate machinery. However, avoid driving or operating machinery if you feel tired or weak after receiving Vestrant 250 Injection 1's.
Liver
Caution
Vestrant 250 Injection 1's is not recommended for patients with severe liver problems. Therefore, if you have liver problems, inform your doctor before receiving Vestrant 250 Injection 1's.
Kidney
Caution
If you have kidney problems, inform your doctor before receiving Vestrant 250 Injection 1's.
Children
Unsafe
Vestrant 250 Injection 1's is not recommended for children and adolescents below 18 years of age.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Product Substitutes